End Taxpayer Funding of Gender Experimentation Act of 2023

Hozzl · 2024-12-20T09:06:24Z

Explore the details of House Bill 3329 End Taxpayer Funding of Gender Experimentation Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/20/2024, 9:06 AM

Summary of Bill HR 3329

Bill 118 HR 3329, also known as the End Taxpayer Funding of Gender Experimentation Act of 2023, aims to prohibit the use of federal funds for gender reassignment surgeries and treatments. The bill specifically targets taxpayer dollars that would be used to cover these procedures for individuals seeking to transition from one gender to another.

Supporters of the bill argue that taxpayer money should not be used to fund what they refer to as "gender experimentation," and that individuals should be responsible for covering the costs of these procedures themselves. They also argue that there are more pressing healthcare needs that should be prioritized with federal funds.

Opponents of the bill argue that denying coverage for gender reassignment procedures is discriminatory and goes against the rights of transgender individuals. They argue that these procedures are medically necessary for some individuals and should be covered by insurance, including federal programs. The bill has sparked debate among lawmakers and advocacy groups, with both sides presenting strong arguments for and against its passage. As of now, the bill is still in the early stages of the legislative process and its ultimate fate remains uncertain.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 3329

Bill HR 3329 is currently in the status of Bill Introduced since May 15, 2023. Bill HR 3329 was introduced during Congress 118 and was introduced to the House on May 15, 2023. Bill HR 3329's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 3329

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 3329

Primary Policy Focus

Health

Potential Impact Areas

Drug therapyHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingSex, gender, sexual orientation discriminationSurgery and anesthesia

Alternate Title(s) of Bill HR 3329

End Taxpayer Funding of Gender Experimentation Act of 2023End Taxpayer Funding of Gender Experimentation Act of 2023To prohibit taxpayer-funded gender transition procedures, and for other purposes.

Start holding our government accountable!